Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Single Cell Analysis Market
Market Size in USD Billion
CAGR :
%
USD
4.78 Billion
USD
15.26 Billion
2024
2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD
4.78 Billion
Market Size (Forecast Year)
USD
15.26 Billion
CAGR
15.60
%
Major Markets Players
BD
Danaher
Merck KGAA
QIAGEN N.V.
Thermo Fisher Scientific Inc. Luminex Corporation
Global Single Cell Analysis Market Segmentation, By Product (Consumables, and Instruments), Cell Type (Animal Cells, Microbial Cells, and Human Cells), Technique (Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, and Other Techniques), Application (Research Applications, and Medical Applications), End User (Hospitals and Diagnostic Laboratories, Cell Banks and IVF centers, Biotechnology and Biopharmaceutical Companies, Research and Academic Laboratories) - Industry Trends and Forecast to 2032
Single Cell Analysis Market Size
The global single cell analysis market size was valued at USD 4.78 billion in 2024 and is expected to reach USD 15.26 billion by 2032,at a CAGR of 15.6% during the forecast period
This growth is driven by factors such as the rising incidence of cancer and chronic diseases, advancements in genomics and transcriptomics technologies, and growing focus on personalized medicine
Single Cell Analysis Market Analysis
Single cell analysis technologies are essential tools in biomedical research, enabling the examination of cellular heterogeneity and providing critical insights into complex biological systems. These technologies are widely used in cancer research, immunology, neurology, and stem cell research
The demand for single cell analysis is significantly driven by the rising incidence of chronic diseases, increasing focus on personalized medicine, and advancements in genomics technologies, such as next-generation sequencing (NGS) and microfluidics
North America is expected to dominate the single-cell analysis market, accounting for approximately 45.3% of global revenue in 2022. This dominance is attributed to advanced research infrastructure, robust funding for life sciences, and a strong presence of key biotechnology and pharmaceutical companies
Asia-Pacific is expected to be the fastest growing region the highest growth rate in the single cell analysis market with 26.8% market share, with countries investing heavily in life sciences R&D and genomics infrastructure
The consumables segment is anticipated to dominate the single-cell analysis market, holding a significant share of approximately 56.7% in 2025. This dominance is attributed to the essential role of consumables in single-cell processing, isolation, and analysis. Consumables such as reagents, assays, beads, and kits are critical components used repeatedly across experiments, leading to consistent demand
Report Scope and Single Cell Analysis Market Segmentation
Attributes
Single Cell Analysis Key Market Insights
Segments Covered
By Product: Consumables, and Instruments
By Cell Type: Animal Cells, Microbial Cells, and Human Cells
By Technique: Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Other Techniques
By Application: Research Applications, and Medical Applications
By End User: Hospitals and Diagnostic Laboratories, Cell Banks and IVF centers, Biotechnology and Biopharmaceutical Companies, and Research and Academic Laboratories
Expansion of Personalized Medicine and Targeted Therapies
Integration of Artificial Intelligence and Machine Learning
Value Added Data Infosets
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Single Cell Analysis Market Trends
“Technological Advancements in Single Cell Analysis Tools”
One of the most notable trends in the evolution of the single cell analysis market is the rapid advancement of technologies, including microfluidics, high-throughput sequencing, and imaging systems
These innovations allow researchers to isolate and analyze individual cells with high precision, enabling deeper insights into cellular heterogeneity, gene expression, and disease mechanisms
For instance, advancements in single-cell RNA sequencing (scRNA-seq) have revolutionized cancer research by allowing scientists to identify rare tumor subpopulations and understand tumor microenvironments at unprecedented resolution
These technological breakthroughs are transforming biomedical research and clinical diagnostics, driving demand for next-generation single cell platforms and expanding their application across oncology, neurology, immunology, and regenerative medicine
Single Cell Analysis Market Dynamics
Driver
“Rising Demand for Personalized Medicine and Genomic Research”
The growing emphasis on personalized medicine and precision therapeutics is a major driver for the single cell analysis market, as it enables researchers to understand cellular heterogeneity at an individual cell level
Single cell technologies help identify rare cell populations, gene expression variability, and disease-specific biomarkers, which are critical for designing targeted therapies
Increasing adoption of next-generation sequencing (NGS) and advancements in molecular biology tools are further supporting the integration of single cell analysis in drug discovery and clinical diagnostics
For instance,
In October 2024, according to a report published by Nature Reviews Genetics, single cell RNA sequencing (scRNA-seq) has become a key tool in decoding complex cellular ecosystems, facilitating the development of individualized treatment plans for cancer and autoimmune disorders
This rising utility in precision medicine and increasing funding for genomic research initiatives globally is expected to drive market expansion
Opportunity
“Technological Advancements in Microfluidics and Imaging Technologies”
Advancements in microfluidics and high-resolution imaging have opened new opportunities in the single cell analysis market, allowing for more accurate and efficient isolation, manipulation, and monitoring of individual cells
Microfluidic platforms reduce sample volumes and reagent costs, while enabling high-throughput analysis, making single cell workflows more scalable and accessible
Integration of real-time imaging, flow cytometry, and AI-based data analytics is further improving throughput and data interpretation
For instance,
In February 2025, a report from the American Chemical Society highlighted the development of next-gen microfluidic chips capable of sorting and profiling thousands of cells simultaneously with minimal loss, significantly boosting the speed and accuracy of single cell experiments
These innovations are expected to accelerate applications in oncology, immunology, neurology, and stem cell research
Restraint/Challenge
“High Cost and Complex Data Interpretation”
The high cost of single cell analysis instruments and consumables presents a major restraint, particularly for small-scale laboratories and research institutions with limited budgets
In addition, the vast and complex datasets generated during single cell studies require advanced computational tools and expertise for interpretation, posing a barrier to adoption
Many facilities face difficulties in integrating bioinformatics pipelines and managing the large volumes of data effectively
For instance,
According to an August 2024 article by BioTechniques, researchers noted that the cost per single cell sequencing experiment could exceed several thousand dollars, limiting its routine use in clinical labs
These factors hinder widespread adoption, particularly in developing regions, and call for innovations to reduce costs and streamline analysis
Single Cell Analysis Market Scope
The market is segmented on the basis of product, cell type, technique and application.
In 2025, the consumables is projected to dominate the market with a largest share in product segment
The consumables segment is expected to dominate the single cell analysis market with the largest share of 56.7% in 2025 due to their essential role in single cell processing, isolation, and analysis. As critical components used repeatedly across experiments, consumables such as reagents, assays, beads, and kits experience consistent demand. The growing number of genomic studies and the widespread adoption of high-throughput workflows further contribute to the segment's market dominance.
The next generation sequencing is expected to account for the largest share during the forecast period in technique market
In 2025, the next-generation sequencing segment is expected to dominate the single cell analysis market with the largest market share of 31.5% due to its ability to provide in-depth analysis of gene expression at a single cell level. As the preferred technique in research applications such as oncology, immunology, and developmental biology, advancements in sequencing technologies and the declining cost of NGS are driving its widespread adoption across academic and clinical research settings.
Single Cell Analysis Market Regional Analysis
“North America Holds the Largest Share in the Single Cell Analysis Market”
North America dominates the single cell analysis market with a market share of 45.3% in 2025, driven by advanced research infrastructure, robust funding for life sciences, and a strong presence of key biotechnology and pharmaceutical companies
U.S. alone accounts for approximately 76.4% of the North American market share, owing to the high adoption of next-generation sequencing technologies, a large base of research institutions, and significant government and private sector investments in precision medicine and genomics
Favourable regulatory frameworks and well-established academic partnerships further strengthen the regional market, along with continuous advancements in single-cell genomics and proteomics research
“Asia-Pacific is Projected to Register the Highest CAGR in the Single Cell AnalysisMarket”
Asia-Pacific is expected to witness the highest growth rate in the single cell analysis market with 26.8% market share, with countries investing heavily in life sciences R&D and genomics infrastructure
China and Japan represent the most significant markets due to their strong government focus on biomedical research and technological innovation
India is expected to register the highest CAGR of 18.4%within the region, supported by expanding biotech clusters, a growing research base, and increasing public and private investments in cellular and molecular biology
The rising prevalence of chronic diseases and growing demand for targeted therapies are fueling the need for single-cell technologies across the Asia-Pacific region
Single Cell Analysis Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
Latest Developments in Global Single Cell Analysis Market
In January 2025, Thermo Fisher Scientific announced the launch of its new Ion Proton system for next-generation sequencing (NGS), aimed at enhancing single-cell RNA sequencing applications. The system is designed to improve throughput, accuracy, and reduce costs for single-cell analysis, enabling better insights into gene expression and cellular heterogeneity in cancer, immunology, and neuroscience
In December 2024, BD (Becton, Dickinson and Company) unveiled its latest BD FACSCellQuest Pro software for single-cell analysis, which integrates enhanced data analysis tools, improving the precision of flow cytometry. The software allows researchers to gain deeper insights into immune system disorders and cancer, making it easier to detect rare cell populations
In November 2024, 10x Genomics launched its Chromium X platform, a breakthrough in single-cell sequencing technology. The platform offers increased throughput and scalability, enabling high-quality, high-throughput gene expression analysis at the single-cell level. It is expected to be pivotal in accelerating breakthroughs in oncology and immunotherapy
In October 2024, QIAGEN N.V. announced the launch of its new Single Cell RNA-Seq Kit, designed for high-resolution transcriptome analysis. This kit allows researchers to explore gene expression patterns at a single-cell level, helping to advance discoveries in personalized medicine, regenerative medicine, and cancer research
SKU-10805
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Frequently Asked Questions
Who are major players in single cell analysis market?
Companies such as BD (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), QIAGEN (Netherlands) and Thermo Fisher Scientific Inc. (U.S.) are the major companies in the single cell analysis market.
What are the recent product launches by major companies in the single cell analysis market?
In January 2025, Thermo Fisher Scientific announced the launch of its new Ion Proton system for next-generation sequencing (NGS), aimed at enhancing single-cell RNA sequencing applications. The system is designed to improve throughput, accuracy, and reduce costs for single-cell analysis, enabling better insights into gene expression and cellular heterogeneity in cancer, immunology, and neuroscience
Which countries data is covered in the single cell analysis market?
The countries covered in the single cell analysis market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future